# OnCo record bud-romine (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/bud-romine/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "bud-romine" ;
  schema:name "Bud Romine"@en ;
  schema:description "A retired railway engineer from Oregon with chronic myeloid leukaemia, he was the first person to take the drug that became Gleevec, in June 1998, after reading about Brian Druker's research in a newspaper."@en ;
  schema:url <https://onco.cc/people/bud-romine/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://www.ohsu.edu/knight-cancer-institute>, <https://en.wikipedia.org/wiki/Imatinib> ;
  onco:tag "hero", "patient" ;
  schema:jobTitle "First patient in the imatinib (STI571) phase 1 trial" ;
  onco:cancers <https://onco.cc/cancers/cml/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/bcr-abl/> ;
  onco:drugs <https://onco.cc/drugs/imatinib/> ;
  onco:terms <https://onco.cc/terms/oncogene-addiction/> ;
  onco:people <https://onco.cc/people/brian-druker/>, <https://onco.cc/people/janet-rowley/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-trial-enrolment/> .